(Q74502732)
Statements
Anti-prothrombin antibodies combined with lupus anti-coagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus (English)
J Nojima
H Kuratsune
E Suehisa
Y Futsukaichi
H Yamanishi
T Machii
T Kitani
Y Iwatani
1 September 2001